Targeting EGFR in non-small-cell lung cancer

被引:23
|
作者
Doroshow, JH [1 ]
机构
[1] NCI, Div Canc Treatment & Diag, Bethesda, MD 20892 USA
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2005年 / 353卷 / 02期
关键词
D O I
10.1056/NEJMe058113
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:200 / 202
页数:3
相关论文
共 50 条
  • [31] The landscape of EGFR pathways and personalized management of non-small-cell lung cancer
    Cheng, Liang
    Zhang, Shaobo
    Alexander, Riley
    Yao, Yongxue
    MacLennan, Gregory T.
    Pan, Chong-xian
    Huang, Jiaoti
    Wang, Mingsheng
    Montironi, Rodolfo
    Lopez-Beltran, Antonio
    FUTURE ONCOLOGY, 2011, 7 (04) : 519 - 541
  • [32] Concomitant EGFR Mutation and ALK Rearrangement in Non-Small-Cell Lung Cancer
    Chen, R.
    Zhang, X.
    Wu, Y.
    Chen, H.
    Zhou, Q.
    Su, J.
    Tu, H.
    Xie, Z.
    Zhong, W.
    Yang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2225 - S2226
  • [33] Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer
    Wu, Yi-Long
    Tsuboi, Masahiro
    He, Jie
    John, Thomas
    Grohe, Christian
    Majem, Margarita
    Goldman, Jonathan W.
    Laktionov, Konstantin
    Kim, Sang-We
    Kato, Terufumi
    Vu, Huu-Vinh
    Lu, Shun
    Lee, Kye-Young
    Akewanlop, Charuwan
    Yu, Chong-Jen
    de Marinis, Filippo
    Bonanno, Laura
    Domine, Manuel
    Shepherd, Frances A.
    Zeng, Lingmin
    Hodge, Rachel
    Atasoy, Ajlan
    Rukazenkov, Yuri
    Herbst, Roy S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (18): : 1711 - 1723
  • [34] EGFR Mutations in Non-Small-Cell Lung Cancer Find, Divide, and Conquer
    Morgensztern, Daniel
    Politi, Katerina
    Herbst, Roy S.
    JAMA ONCOLOGY, 2015, 1 (02) : 146 - 148
  • [35] Non-small-cell lung cancer harbouring mutations in the EGFR kinase domain
    Rosell, Rafael
    Moran, Teresa
    Carcereny, Enric
    Quiroga, Vanessa
    Angel Molina, Miguel
    Costa, Carlota
    Benlloch, Susana
    Taron, Miquel
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2010, 12 (02): : 75 - 80
  • [36] EGFR-directed therapies to treat non-small-cell lung cancer
    Ho, Cheryl
    Laskin, Janessa
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (08) : 1133 - 1145
  • [37] Spontaneously expectorated EGFR-mutant non-small-cell lung cancer
    Sumi, Toshiyuki
    Terai, Kotomi
    Chiba, Hirofumi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 53 (11) : 1094 - 1095
  • [38] Influence of polymorphisms on EGFR targeted therapy in non-small-cell lung cancer
    Giovannetti, Elisa
    Erdem, Lale
    Olcay, Efnan
    Leon, Leticia G.
    Peters, Godefridus J.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2011, 16 : 116 - 130
  • [39] Metastatic non-small-cell lung cancer with EGFR mutation - case report
    Jasiowka, Marek
    Cedrych, Ida
    ONCOLOGY IN CLINICAL PRACTICE, 2014, 10 : G46 - G48
  • [40] Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR.
    Maemondo, Makoto
    Inoue, Akira
    Kobayashi, Kunihiko
    Sugawara, Shunichi
    Oizumi, Satoshi
    Isobe, Hiroshi
    Gemma, Akihiko
    Harada, Masao
    Yoshizawa, Hirohisa
    Kinoshita, Ichiro
    Fujita, Yuka
    Okinaga, Shoji
    Hirano, Haruto
    Yoshimori, Kozo
    Harada, Toshiyuki
    Ogura, Takashi
    Ando, Masahiro
    Miyazawa, Hitoshi
    Tanaka, Tomoaki
    Saijo, Yasuo
    Hagiwara, Koichi
    Morita, Satoshi
    Nukiwa, Toshihiro
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (25): : 2380 - 2388